Antithrombin Market Size, Share & Industry Analysis, By Source (Human Plasma and Others), By Application (Therapeutic and Research & Diagnostic), By Dosage Form (Lyophilized Powder and Liquid), By End User (Hospitals & Clinics, Pharmaceutical & Biotechnology Industry, and Research Institutes), and Regional Forecast, 2025-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI100470

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascular Diseases, By Key Countries
2. Regulatory Scenario, By Key Countries
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
4. Impact of COVID-19 on the Market
5. Overview: Antithrombin Market in Japan & South Korea
Global Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Rest of World Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. CSL
  2. Octapharma AG
  3. Takeda Pharmaceutical Company Limited
  4. Grifols, S.A.
  5. Medix Biochemica
  6. Kedrion S.p.A.
  7. Scripps Laboratories
  8. LFB

Introduction
1. Market Scope
2. Market Segmentation
3. Market Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. Prevalence of Key Cardiovascular Diseases, By Key Countries
2. Regulatory Scenario, By Key Countries
3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Approvals, Launches etc.)
4. Impact of COVID-19 on the Market
5. Overview: Antithrombin Market in Japan & South Korea
Global Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Rest of the World
North America Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country
  1. U.S.
  2. Canada
Europe Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Germany
  2. UK
  3. France
  4. Italy
  5. Spain
  6. Scandinavia
  7. Rest of Europe
Asia Pacific Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
5. Market Analysis, Insights and Forecast – By Country/Sub-region
  1. Japan
  2. China
  3. India
  4. Australia
  5. South Korea
  6. Southeast Asia
  7. Rest of Asia Pacific
Rest of World Antithrombin Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Source
  1. Human Plasma
  2. Others
2. Market Analysis, Insights and Forecast – By Application
  1. Therapeutic
  2. Research & Diagnostic
3. Market Analysis, Insights and Forecast – By Dosage Form
  1. Lyophilized Powder
  2. Liquid
4. Market Analysis, Insights and Forecast – By End User
  1. Hospitals & Clinics
  2. Pharmaceutical & Biotechnology Industry
  3. Research Institutes
Competitive Analysis
1. Global Market Share Analysis (2024)
2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  1. CSL
  2. Octapharma AG
  3. Takeda Pharmaceutical Company Limited
  4. Grifols, S.A.
  5. Medix Biochemica
  6. Kedrion S.p.A.
  7. Scripps Laboratories
  8. LFB

Read Less

List of Figures

Figure 1: Global Antithrombin Market Revenue Breakdown (USD million, %) by Region, 2024 & 2032

Figure 2: Global Antithrombin Market Value Share (%), by Source, 2024 & 2032

Figure 3: Global Antithrombin Market Value Share (%), by Dosage Form, 2024 & 2032

Figure 4: Global Antithrombin Market Value Share (%), by Application, 2024 & 2032

Figure 5: Global Antithrombin Market Value Share (%), by End User, 2024 & 2032

Figure 6: Global Antithrombin Market Value (USD million), by Region, 2024 & 2032

Figure 7: North America Antithrombin Market Value (USD million), by Source, 2024 & 2032

Figure 8: North America Antithrombin Market Value Share (%), by Source, 2024

Figure 9: North America Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 10: North America Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 11: North America Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 12: North America Antithrombin Market Value Share (%), by Application, 2024

Figure 13: North America Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 14: North America Antithrombin Market Value Share (%), by End User, 2024

Figure 15: North America Antithrombin Market Value (USD million), By Country, 2024 & 2032

Figure 16: North America Antithrombin Market Value Share (%), By Country, 2024

Figure 17: Europe Antithrombin Market Value (USD million), by Source, 2024 & 2032

Figure 18: Europe Antithrombin Market Value Share (%), by Source, 2024

Figure 19: Europe Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 20: Europe Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 21: Europe Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 22: Europe Antithrombin Market Value Share (%), by Application, 2024

Figure 23: Europe Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 24: Europe Antithrombin Market Value Share (%), by End User, 2024

Figure 25: Europe Antithrombin Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 26: Europe Antithrombin Market Value Share (%), By Country/ Sub-region, 2024

Figure 27: Asia Pacific Antithrombin Market Value (USD million), by Source, 2024 & 2032

Figure 28: Asia Pacific Antithrombin Market Value Share (%), by Source, 2024

Figure 29: Asia Pacific Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 30: Asia Pacific Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 31: Asia Pacific Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 32: Asia Pacific Antithrombin Market Value Share (%), by Application, 2024

Figure 33: Asia Pacific Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 34: Asia Pacific Antithrombin Market Value Share (%), by End User, 2024

Figure 35: Asia Pacific Antithrombin Market Value (USD million), By Country/ Sub-region, 2024 & 2032

Figure 36: Asia Pacific Antithrombin Market Value Share (%), By Country/ Sub-region, 2024

Figure 37: Rest of the World Antithrombin Market Value (USD million), by Source, 2024 & 2032

Figure 38: Rest of the World Antithrombin Market Value Share (%), by Source, 2024

Figure 39: Rest of the World Antithrombin Market Value (USD million), by Dosage Form, 2024 & 2032

Figure 40: Rest of the World Antithrombin Market Value Share (%), by Dosage Form, 2024

Figure 41: Rest of the World Antithrombin Market Value (USD million), by Application, 2024 & 2032

Figure 42: Rest of the World Antithrombin Market Value Share (%), by Application, 2024

Figure 43: Rest of the World Antithrombin Market Value (USD million), by End User, 2024 & 2032

Figure 44: Rest of the World Antithrombin Market Value Share (%), by End User, 2024

Figure 45: Global Antithrombin Market Share (%), By Company, 2024

List of Tables

Table 1: Global Antithrombin Market Revenue (USD million) Forecast, by Source, 2019–2032

Table 2: Global Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019–2032

Table 3: Global Antithrombin Market Revenue (USD million) Forecast, by Application, 2019–2032

Table 4: Global Antithrombin Market Revenue (USD million) Forecast, by End User, 2019–2032

Table 5: Global Antithrombin Market Revenue (USD million) Forecast, by Region, 2019-2032

Table 6: North America Antithrombin Market Revenue (USD million) Forecast, by Source, 2019-2032

Table 7: North America Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 8: North America Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 9: North America Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

Table 10: North America Antithrombin Market Revenue (USD million) Forecast, By Country, 2019-2032

Table 11: Europe Antithrombin Market Revenue (USD million) Forecast, by Source, 2019-2032

Table 12: Europe Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 13: Europe Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 14: Europe Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

Table 15: Europe Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

Table 16: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by Source, 2019-2032

Table 17: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 18: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 19: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

Table 20: Asia Pacific Antithrombin Market Revenue (USD million) Forecast, By Country/ Sub-region, 2019-2032

Table 21: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by Source, 2019-2032

Table 22: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by Dosage Form, 2019-2032

Table 23: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by Application, 2019-2032

Table 24: Rest of the World Antithrombin Market Revenue (USD million) Forecast, by End User, 2019-2032

STUDY PERIOD: 2019-2032
BASE YEAR: 2024
HISTORICAL DATA: 2019-2023
NO OF PAGES: 123

(Offer valid till 15^th Dec 2025)

Download Free Sample

Security Code

Growth Advisory Services

How can we help you uncover new opportunities and scale faster?

Clients

Related Reports

Heparin Market

Anticoagulants Market

Plasma Fractionation Market

Extra Corporeal Membrane Oxygenation (ECMO) Market

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)

sales@fortunebusinessinsights.com